The patterns of PD-L1 mRNA expression in plasma-derived exosomes at baseline corresponded to response to atezolizumab plus nab-paclitaxel and survival in patients with triple negative breast cancer
Log in met Medi-Access
Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen
PD-L1 mRNA Baseline Expression May Indicate Response to Atezolizumab Plus Nab-paclitaxel in TNBC
European Society for Medical Oncology (ESMO) | Geplaatst op 01.03.2021 09:24